Astellas Pharma US
Pharmaceutical company
Based in IL
AI Overview
With $1.3M in lobbying spend across 34 quarterly filings, Astellas Pharma US is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $160K |
| 2019 | $160K |
| 2020 | $160K |
| 2021 | $160K |
| 2022 | $160K |
| 2023 | $160K |
| 2024 | $200K |
| 2025 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Astellas Pharma US disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Defense, Law Enforcement
Issues related to pharmaceuticals and health care.
National Defense Authorization Act for Fiscal Year 2019
Issues related to pharmaceutical pricing and NIH March In Rights
Issues related to pharmaceutical pricing
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.